DarioHealth Corp. announced a new contract to provide cardiometabolic and GLP-1 solutions to a national employer (the "Employer") beginning in January 2024. The Employer, a national logistics company, selected Dario to deliver integrated support for employees living with diabetes, pre-diabetes, weight management and hypertension, while also providing a tailored experience for employees taking a GLP-1 medication.

Dario combines intelligent technologies and expert human support with billions of data insights gathered from a decade of consumer engagement to deliver highly personalized experiences that keep people engaged over time for optimal results.